Interactions of iron(II) octacarboxyphthalocyanine with levamisole hydrochloride
Source abstract
Abstract
The interaction of veterinary drug levamisole hydrochloride (LEV-HCl) with iron(II) octacarboxyphthalocyanine (FePcOC) was studied by UV–Vis spectroscopy and density functional theory calculations (DFT, TD-DFT). It was shown that interaction with LEV caused bathochromic shift of the Q-band of FePcOC. Oxidation of LEV using H2O2 and FePcOC as catalyst showed that the main product was the disulphide dimer of a thiol decomposition product, being a result of a thiol ring opening, as shown through LCMS. Furthermore, a dihydroimidazole product of LEV ([M+H]+ 203.06), potentially arising from an imidazolidine ring dehydrogenation, was identified. The effect of the interaction effect with LEV on the molecular geometry of FePcOC was investigated at the M06-2X/6-31G+(d,p) level. TD-DFT calculations revealed a bathochromic shift of the FePcOC Q band due to the axial coordination via the nitrogen atom of levamisole.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Metal-Catalyzed Oxygenation Mechanisms · Free Radicals and Antioxidants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Metallophthalocyanine-based molecular materials as catalysts for electrochemical reactions10.1016/j.ccr.2010.05.001 ↗
2. Phthalocyanine metal complexes in catalysis10.1021/cr4000072 ↗
3. Photocatalysis of 4-nitrophenol using zinc phthalocyanine complexes10.1016/j.molcata.2006.07.055 ↗
4. Copper octacarboxyphthalocyanine as sensitizer of graphitic carbon nitride for efficient dye degradation under visible light irradiation10.1016/j.apcata.2018.06.036 ↗
5. Photoelectrochemical characterization of electrodeposited ZnO thin films sensitized by octacarboxymetallophthalocyanine derivatives10.1142/S1088424610001854 ↗
6. A novel pro-apoptotic role of zinc octacarboxyphthalocyanine in melanoma me45 cancer cell's photodynamic therapy (PDT)10.1016/j.jphotobiol.2018.12.002 ↗
7. Interactions of amino acids with aluminum octacarboxyphthalocyanine hydroxide. Experimental and DFT studies10.1007/s00894-017-3222-2 ↗
8. Spectral studies of zinc octacarboxyphthalocyanine aggregation10.1016/j.dyepig.2008.06.009 ↗
9. Synthesis and selected properties of metallo and metal-free 2,3,9,10,16,17,23,24 –octacarboxyphthalocyanines
10. Metallophthalocyanines as catalysts in aerobic oxidation10.3390/catal11010122 ↗
11. Oxidative degradation of pharmaceuticals: the role of tetrapyrrole-based catalysts10.3390/catal11111335 ↗
12. $μ$-Nitrido diiron macrocyclic platform: particular structure for particular catalysis10.1021/acs.accounts.5b00458 ↗
13. Electrocatalytic oxidation and detection of hydrazine at gold electrode modified with iron phthalocyanine complex linked to mercaptopyridine self-assembled monolayer10.1016/j.talanta.2005.02.030 ↗
14. Highly selective oxidation of benzyl alcohol catalyzed by new peripherally tetra-substituted Fe (II) and Co (II) phthalocyanines10.1016/j.synthmet.2014.09.022 ↗
15. Iron(II)-phthalocyanine as a novel recognition sensor for selective potentiometric determination of diclofenac and warfarin drugs10.1016/j.jpba.2005.03.027 ↗
16. Metallophthalocyanines as catalysts in electrochemical reactions10.1016/0010-8545(92)80031-L ↗
17. Axial ligand exchange reactions of ferrous phthalocyanine. Exchange of imidazole for dimethyl sulfoxide10.1021/ic50080a016 ↗
18. Interaction of phthalocyaninatoiron(II) with molecular oxygen. Kinetics and mechanism of the reaction in dimethyl sulphoxide10.1016/S0020-1693(00)90832-6 ↗
19. Equilibrium and kinetic study of pyridine binding to phthalocyaninatoiron(II) in dimethyl sulphoxide
20. Equilibrium and kinetic study of the reaction between phthalocyaninatoiron(II) and carbon monoxide in dimethyl sulphoxide in the presence of pyridine. Evidence for the formation of a transient
21. Equilibrium and kinetic study of imidazole binding to phthalocyaninatoiron(II) in dimethyl sulphoxide
22. Spectrophotometric and electrochemical studies of the interaction between iron(II) tetrasulfophthalocyanine and histamine10.1142/S1088424602000233 ↗
23. Alzheimer's disease10.1056/NEJMra0909142 ↗
24. The dopamine hypothesis of schizophrenia: version III--The final common pathway10.1093/schbul/sbp006 ↗
25. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis10.1006/exnr.2000.7397 ↗
26. Interaction between iron(II) tetrasulfophthalocyanine and the neurotransmitters, serotonin and dopamine10.1016/S0277-5387(00)00421-6 ↗
27. Octabutylthiophthalocyaninatoiron(ii): electrochemical properties and interaction with cyanide10.1039/b111429h ↗
28. Interaction of cyanide with iron(II) phthalocyanine: kinetics and equilibria
29. The reaction of cyanide with iron(II) hexadecachlorophthalocyanine10.1016/0277-5387(94)00291-L ↗
30. Non-steroidal anti-inflammatory drugs (NSAIDs) in the environment: recent updates on the occurrence, fate, hazards and removal technologies10.1016/j.scitotenv.2023.166897 ↗
31. Removal of environmentally toxic sulfamethoxazole waste using TiO2-graphite systems and a tailor-made LED photoreactor: unraveling the role of spectra-matching10.1016/j.apsusc.2023.158089 ↗
32. An advanced photo-oxidation process for pharmaceuticals using plasmon-assisted Ag-CoFe2O4 photocatalysts10.1016/j.chemosphere.2023.139984 ↗
33. Acute toxicity to freshwater organisms of antiparasitic drugs for veterinary use10.1002/tox.20078 ↗
34. Mikrozanieczyszczenia w środowisku–występowanie, interakcje, usuwanie
35. Unravelling the performance of UV/H2O2 on the removal of pharmaceuticals in real industrial, hospital, grey and urban wastewaters10.1016/j.chemosphere.2021.133315 ↗
36. Speciation of iron in the aquatic environment10.2175/106143014X13975035525906 ↗
37. Oxidation of diclofenac in the presence of iron(II) octacarboxyphthalocyanine
38. Comparison of the degradation mechanisms of diclofenac in the presence of iron octacarboxyphthalocyanine and myeloperoxidase10.1016/j.saa.2022.122113 ↗
39. Synthesis and electrical properties of one-dimensional octacyanometallophthalocyanine (M≡Fe, Co) polymers10.1002/(SICI)1099-1409(200001/02)4:1<136::AID-JPP213>3.0.CO;2-J ↗
40. Oxidation of diclofenac in the presence of iron(II) octacarboxyphthalocyanine10.1016/j.chemosphere.2020.129145 ↗
41. Frisch · 2016
42. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other function10.1007/s00214-007-0310-x ↗
43. Quantum mechanical continuum solvation models10.1021/cr9904009 ↗
44. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors10.1080/00268977000101561 ↗
45. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint10.1021/cr00088a005 ↗
46. Zirconium oxide nanoparticles modified carbon paste electrode for simultaneous voltammetric determination of mebendazole and levamisole hydrochloride in pharmaceutical formulation and human plasma10.1002/elan.202100559 ↗
47. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement10.1124/dmd.112.045021 ↗
48. Leznoff · 1989 · 139
49. Interactions of histidine and other imidazole derivatives with transition metal ions in chemical and biological systems10.1021/cr60290a003 ↗
50. Zirconium oxide nanoparticles modified carbon paste electrode for simultaneous voltammetric determination of mebendazole and levamisole hydrochloride in pharmaceutical formulation and human plasma10.1002/elan.202100559 ↗
51. Iron(III) phthalocyanines: oxidation and spin states of iron in iron phthalocyanines with carboxyl groups
52. A mononuclear high-spin iron(III) phthalocyanine
53. Interactions of histidine and other imidazole derivatives with transition metal ions in chemical and biological systems10.1021/cr60290a003 ↗
54. Levamisole: a common adulterant in cocaine street samples hindering electrochemical detection of cocaine10.1021/acs.analchem.8b00204 ↗
55. Stability-indicating high-performance liquid chromatographic determination of levamisole hydrochloride in bulk and dosage forms10.1155/2020/6137897 ↗
56. Development and validation of a simple stability-indicating TLC method for the determination of levamisole in pharmaceutical tablet formulation10.1556/JPC.24.2011.5.10 ↗
57. Treatment of wastewater effluents from Bogotá – Colombia by the photo-electro-Fenton process: elimination of bacteria and pharmaceutical10.1016/j.scitotenv.2020.144890 ↗
58. Rapid and selective oxidation of metallosulfophthalocyanines prior to their usefulness as precatalysts in oxidation reactions10.1002/ejic.200200620 ↗
59. Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS10.1007/s00216-013-6829-x ↗
60. Aminorex and rexamino as metabolites of levamisole in the horse10.1016/j.aca.2009.02.033 ↗
61. Roberts · 1994 · 805
62. Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria10.3109/00498259109039513 ↗
63. Dusi · 2019
64. Immunomodulatory action of levamisole — I. Structural analysis and immunomodulating activity of levamisole degradation products10.1016/0192-0561(91)90178-A ↗
65. Immunomodulatory action of levamisole — II. Enhancement of concanavalin a response by levamisole is associated with an oxidation degradation product of levamisole formed during lymphocyte culture10.1016/0192-0561(91)90179-B ↗
66. Magnetism of phthalocyanine-based organometallic single porous sheet10.1021/ja204990j ↗
67. Comparative study of metal‐porphyrins, ‐porphyrazines, and ‐phthalocyanines10.1002/jcc.10142 ↗
68. Non-covalent control of spin-state in metal-organic complex by positioning on N-doped graphene10.1038/s41467-018-05163-y ↗
69. Theoretical investigation of the molecular and electronic structures and excitation spectra of iron phthalocyanine and its derivatives, FePc and FePcLn (L = Py, CN−; n = 1, 2)10.1039/b823309h ↗
70. Synthesis, thermal stability and structural characterisation of iron(II) phthalocyanine complex with 4-cyanopyridine10.1016/j.poly.2007.01.040 ↗
71. Structural characterization of two modifications of bis(4-methylpyridine)phthalocyaninato(2-)iron(II) complex10.1080/00958972.2012.696622 ↗
72. Computational approach to understand the adsorption behavior of iron(II) phthalocyanine on the doped graphene surface10.1021/acs.jpcc.8b11357 ↗